Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $180.1600 (1.55%) ($167.8400 - $180.1600) on Thu. Feb. 4, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.86% (three month average) | RSI | 86 | Latest Price | $180.1600(1.55%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -1.5% a day on average for past five trading days. | Weekly Trend | LGND advances 16.9% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(56%) IWO(54%) IWM(51%) XBI(50%) IWC(49%) | Factors Impacting LGND price | LGND will decline at least -1.93% in a week (0% probabilities). VIXM(-26%) UUP(-18%) VXX(-15%) UNG(-3%) USO(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.93% (StdDev 3.86%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $179.96(0.11%) | 10 Day Moving Average | $171.95(4.77%) | 20 Day Moving Average | $146.94(22.61%) | To recent high | -7.1% | To recent low | 121.3% | Market Cap | $2.895b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |